Skip to main content
. Author manuscript; available in PMC: 2011 Oct 31.
Published in final edited form as: J Geriatr Psychiatry Neurol. 2009 Nov 20;23(1):49–53. doi: 10.1177/0891988709351832

Table 1.

Baseline Characteristics

AD Control P Valuea
Number of participants 192 174
Sex (n, %) .0109
    Female 96 (50.0) 110 (63.2)
    Male 96 (50.0) 64 (36.8)
Age (mean, SD) 75.8 (8.2) 70.7 (8.2) <.0001
Range 54–100 49–93
Race/ethnicity (n, %) .7576
    Caucasian 150 (94.3) 144 (93.5)
    Not Caucasian 9 (5.7) 10 (6.5)
Years of education (mean, SD) 14.4 (2.8) 15.0 (2.5) .0486
Range 6–20 8–20
MMSE (mean, SD)b 20.7 (5.6) 29.3 (0.91) <.0001
Range 5–30 25–30
CDR global (mean, SD)c 1.2 (0.6) 0.0 (0.0) <.0001
    0 0 99 (100.0)
    0.5 23 (23.2) 0
    1 47 (47.5) 0
    2 29 (29.3) 0
CDR sum of boxes (mean, SD)d 6.6 (3.6) 0.1 (0.2) <.0001
Range 1.5–18 0–1.0
CRP (µg/mL) 2.9 (4.5) 4.9 (7.7) .003
Log CRPe(mean, SD) 0.3 (1.3) 0.8 (1.2) <.0001
Range −2.8 to 3.6 −.21 to 3.9

NOTES: AD = Alzheimer disease; CDR = clinical dementia rating; CRP = C-reactive protein; MMSE = Mini-Mental State Examination.

a

P values are based on a χ2 test for categorical variables and a t test for continuous variables.

b

MMSE scores were available on 192 AD patients and 174 controls.

c

CDR global scores were available on 99 AD patients and 99 controls.

d

CDR sum of boxes scores were available on 128 AD patients and 115 controls.

e

Log transformation of CRP levels passed the Anderson-Darling test for normality with a P value of .073, therefore comparison based on t test.